Lobbying Information
Subject Matters
- Agriculture
- Budget
- Consumer Issues
- Employment and Training
- Energy
- Environment
- Fisheries
- Forestry
- Government Procurement
- Health
- Immigration
- Industry
- Intellectual Property
- International Relations
- International Trade
- Research and Development
- Science and Technology
- Small Business
- Taxation and Finance
Subject Matter Details
Legislative Proposal, Bill or Resolution, Regulation
- CANADIAN ENVIRONMENTAL PROTECTION ACT AND REGULATIONS in respect of modern, science-based regulations to reflect rapidly changing new technologies
- FOOD AND DRUGS ACT AND REGULATIONS in respect of minimizing regulatory burden and ensuring appropriate climate for the introduction of new technologies
Policies or Program
- ACCESS & BENEFIT SHARING: TRIPS AGREEMENT in respect of protecting intellectual property and preventing increased uncertainty
- ADVENTITIOUS PRESCENCE POLICY in respect of new agricultural biotechnology products
- BIOSAFETY PROTOCOL in respect of Canada's participation in global discussions to ensure an enabling environment for safe new technologies
- Clarify the administration of SR&ED program to ensure clinical trials and international research conducted in Canada qualifies as eligible expenses
- Creation of a modern policy environment that recognizes international standards and reviews, and establishes clarity on data ownership for intellectual property
- Establish accountability with the federally financed Canadian Agency for Drugs and Technologies and Health (CADTH) and its Common Drug Review process (Health Canada)
- FOOD LABELLING in respect of mitigating the unnecessary introduction of new labelling requirements for products already approved under current regulated process and in respect of maintaining harmonization of requirements with trading nations
- IMPROVED TAXATION & INVESTMENT FRAMEWORK in respect of extending Canada's flow-through shares program to biotechnology companies for increased domestic investments.
- IMPROVEMENTS TO THE Scientifc Research & Experimental Development TAX CREDITS in respect of updating the 20 yr old system by removing the punitive Canadian Controlled Private Companies restriction and increasing the expenditure limit for refundable credits
- NOVEL FOODS in respect of maintaining a science-based regulatory system for novel foods derived from plant and animal biotechnology
- PATENTED MEDECINES PRICES REVIEW BOARD (PMPRB) PRICE REVIEW to ensure new guidelines and directives do not create disincentives for the introduction of new treatments in Canada
- RESEARCH & DEVELOPMENT (R&D) in respect on providing input to the government's expert panel on business R&D to improve incentives for research in Canada
- SCIENCE & TECHNOLOGY STRATEGY in respect of encouraging a strong government focus to stimulate the development, use and retention of biotechnology products, processes and companies
- SUBMISSION REVIEW PROCESS FOR BIOLOGICS, COST RECOVERY REVIEW to ensure Canada remains competitive overall and any new costs do not put bioloigics are a comparative disadvantage
- Vaccine Funding - National Immunization Strategy - to re-establish federal leadership in providing provinces with funding for new vaccines under a renewed national immunization strategy framework
- WORLD TRADE ORGANIZATION (WTO) in respect of Canada's contribution and participation to encourage a sound business climate and to faciliate Canada's access to European markets for genetically engineered agricultural and animal products
Policies or Program, Regulation
- INTELLECTUAL PROPERTY/PATENT POLICY AND REGULATIONS in respect of creating Canada as one of the world's most competitive jurisdictions in protecting IP (e.g., match level of European Union via CETA negotiations)
- ORPHAN PRODUCTS to establish formal regulations, policies or programs to encourage the research, development and introduction of new technologies to treat "orphan" or neglected diseases
- REGULATORY APPROVAL PROCESS FOR PLANTS WITH NOVEL TRAITS as NOVEL FOODS or INDUSTRIAL BIO_PRODUCTS in respect of an efficient science-based approach and allows for greater cooperation among and between government departments
- Regulatory framework for subsequent entry biologics to ensure an appropriate and transparent appraoch for the safe introduction of biosimilars
Regulation
- SUBSEQUENT ENTRY BIOLOGICS to establish formal regulations to prescribe the requirements for introduction of biosimilars and ensure the protection of intellectual property for first entry biologics
Communication Techniques
-
Written communication
-
Oral communication
-
Grass-roots communication
Government Institutions
-
Agriculture and Agri-Food Canada (AAFC)
-
Atlantic Canada Opportunities Agency (ACOA)
-
Business Development Bank of Canada (BDC)
-
Canada Revenue Agency (CRA)
-
Canadian Food Inspection Agency (CFIA)
-
Canadian Institutes of Health Research (CIHR)
-
Canadian International Development Agency (CIDA)
-
Citizenship and Immigration Canada
-
Environment Canada
-
Export Development Canada (EDC)
-
Finance Canada (FIN)
-
Fisheries and Oceans Canada (DFO)
-
Foreign Affairs and International Trade Canada (DFAITC)
-
Health Canada (HC)
-
House of Commons
-
Human Resources Development Canada (HRDC)
-
Industry Canada
-
Members of the House of Commons
-
National Research Council (NRC)
-
Natural Resources Canada (NRCan)
-
Natural Sciences and Engineering Research Council (NSERC)
-
Office of the Information and Privacy Commissioner (OIPC)
-
Patented Medicine Prices Review Board (PMPRB)
-
Prime Minister's Office (PMO)
-
Privy Council Office (PCO)
-
Procurement Review Board of Canada (PRB)
-
Public Health Agency of Canada (PHAC)
-
Public Works and Government Services Canada
-
Revenue Canada (RC)
-
Senate of Canada
-
Social Sciences and Humanities Research Council (SSHRC)
-
Statistics Canada (StatCan)
-
Technology Partnerships Canada (TPC)
-
Treasury Board Of Canada Secretariat (TBS)
In-house Organization Details
Description of the organization's activities
BIOTECANADA IS A NOT-FOR-PROFIT ORGANIZATION THAT IS THE VOICE FOR BIOTECHNOLOGY IN CANADA. BIOTECANADA IS DEDICATED TO THE SUSTAINABLE COMMERCIAL DEVELOPMENT OF BIOTECHNOLOGY IN CANADA. IT FOCUSES ON THE ISSUES AND ACTIVITIES AFFECTING THE CANADIAN BIOTECHNOLOGY COMMUNITY, BOTH NATIONALLY AND INTERNATIONALLY. BIOTECANADA IS INVOLVED IN MANY INITIATIVES TO ADDRESS THESE ISSUES, INCLUDING REGULATORY AND POLICY ADVOCACY, FINANCE, AND THE COLLECTION AND DISSEMINATION OF MARKET INFORMATION. BIOTECANADA, IN PARTNERSHIP WITH THE REGIONAL BIOTECHNOLOGY ASSOCIATIONS, REPRESENTS 90 PERCENT OF THE CANADIAN BIOTECHNOLOGY COMMUNITY
Responsible officer name and position during the period of this registration
PETER BRENDERS,
PRESIDENT & Chief Executive Officer
Organization's membership or classes of membership
BIOTECANADA CURRENTLY HAS OVER 200 MEMBERS. THE MEMBERSHIP IS COMPRISED OF COMPANIES IN THE HUMAN HEALTH CARE, AGRICULTURAL, INDUSTRIAL, ENVIRONMENTAL AND SERVICE SECTORS AS WELL AS ASSOCIATIONS AND UNIVERSITIES. THE MEMBERSHIP CATEGORIES ARE: 1. BIOTECHNOLOGY INDUSTRY: FIRMS, CORPORATIONS OR SUBSIDIARIES, DIVISIONS OR UNITS THEREOF WHICH COMMERCIALIZE BIOTECHNOLOGY-DERIVED PRODUCTS AND/OR ARE ACTIVE IN BIOTECHNOLOGY RELATED R&D. 2. SERVICE INDUSTRY: FIRMS, CORPORATIONS OR SUBSIDIARIES, DIVISIONS OR UNITS THEREOF WHICH ARE CHARTERED BANKS OR THEIR SUBSIDIARIES; PROVIDE FINANCIAL, LEGAL, INSURANCE, CONSULTING OR OTHER SERVICES; OR PROVIDE SUPPLIES OR EQUIPMENT. 3. NOT-FOR-PROFIT: REGIONAL/SECTORAL ASSOCIATIONS, ACADEMIC ORGANIZATIONS AND PROFESSIONAL ASSOCIATIONS, GOVERNMENT DEPARTMENTS AND AGENCIES WITH A SCIENCE AND TECHNOLOGY MANDATE, OR FOREIGN ORGANIZATIONS
Government funding
No government funding was received during the last completed financial year.
In-house Organization Contact Information
Address:
600 - 1 NICHOLAS STREET
OTTAWA, ON K1N 7B7
Canada
Telephone number:
613-230-5585
Fax number:
613-563-8850
Lobbyists Details
Employees who lobby for the organization
- Matt Aleksic,
Manager, Health Policy |
No public offices held
- Ron Boch,
Sr Director, Life Sciences |
No public offices held
- PETER BRENDERS,
PRESIDENT & Chief Executive Officer |
No public offices held
- Lynn Buchanan,
VP, Industry Relations |
No public offices held
- Nadine Lunt,
Sr Mgr, Communications |
No public offices held
- CATE MCCREADY,
VP, EXTERNAL AFFAIRS |
Public offices held
- Gibril Muddei,
Director, Industrial Biotechnology |
No public offices held
